TERT and neoplasm: In addition, it was reported that a combination therapy of a BET bromodomain inhibitor, OTX015, and a proteasome inhibitor, carfilzomib, synergistically blocked TERT expression, induced tumor cell apoptosis, suppressed tumor progression and improved survival of a preclinical mouse PDX model, which was largely reversed by forced TERT overexpression.